London, England, United Kingdom Phase4 Ventures is the famous VC, which was founded in 1999. The main department of described VC is located in the London. The company was established in Europe in United Kingdom.
The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Phase4 Ventures, startups are often financed by CMEA Ventures, Sofinnova Investments, Bay City Capital. The meaningful sponsors for the fund in investment in the same round are U.S. Venture Partners (USVP), ProQuest Investments, New Enterprise Associates. In the next rounds fund is usually obtained by Arax Capital Partners, New Enterprise Associates, MPM Capital.
Among the most popular portfolio startups of the fund, we may highlight Nabriva Therapeutics, Chroma Therapeutics, Phenomix. For fund there is no match between the location of its establishment and the land of its numerous investments - United States. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Health Care, Consulting. The fund has exact preference in a number of founders of portfolio startups.
The important activity for fund was in 2007. The increased amount of exits for fund were in 2015. The common things for fund are deals in the range of 50 - 100 millions dollars. The real fund results show that this VC is 36 percentage points more often commits exit comparing to other companies. Comparing to the other companies, this Phase4 Ventures performs on 27 percentage points more the average number of lead investments. The fund is constantly included in less than 2 investment rounds annually. The typical startup value when the investment from Phase4 Ventures is 50-100 millions dollars.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Assembled Brands | New York, New York, United States |
| Consorcio - HCS Capital | Florida, Miami, United States |
| Ding Cheng Fanglue | Beijing, China, Haidian |
| Fly Ventures | Berlin, Berlin, Germany |
| genYcapital | Chicago, Illinois, United States |
| HAT Technology & Innovation Fund | Italy, Lombardia, Lombardy |
| Hongboyuan Touzi | China, Guangdong, Shenzhen |
| Incite Labs, Inc. | - |
| Luxempart | Canton Esch-sur-Alzette, Leudelange, Luxembourg |
| Pace Capital | New York, New York, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Zosano Pharma | $30M | 06 Aug 2009 | Fremont, California, United States | ||
OncoMed Pharmaceuticals | $154M | 04 Nov 2008 | Redwood City, California, United States | ||
Proteolix | $79M | 08 Sep 2008 | South San Francisco, California, United States | ||
Zosano Pharma | $90M | 15 Nov 2007 | Fremont, California, United States | ||
Phenomix | $55M | 08 Mar 2007 | San Diego, California, United States | ||
Chroma Therapeutics | $53M | 03 Apr 2006 | England | ||
| $70M | 26 Oct 2005 | South San Francisco, California, United States | |||
Altus Pharmaceuticals | $51M | 26 May 2004 | Independence, Ohio, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Zosano Pharma | $30M | 06 Aug 2009 | Fremont, California, United States | ||
OncoMed Pharmaceuticals | $154M | 04 Nov 2008 | Redwood City, California, United States | ||
Proteolix | $79M | 08 Sep 2008 | South San Francisco, California, United States | ||
Zosano Pharma | $90M | 15 Nov 2007 | Fremont, California, United States | ||
Phenomix | $55M | 08 Mar 2007 | San Diego, California, United States | ||
Chroma Therapeutics | $53M | 03 Apr 2006 | England | ||
| $70M | 26 Oct 2005 | South San Francisco, California, United States | |||
Altus Pharmaceuticals | $51M | 26 May 2004 | Independence, Ohio, United States |
